PCN35 VALUATION OF SOCIETAL PREFERENCE BETWEEN THERAPIES FOR CANCER-RELATED ANAEMIA (CRA)- RECOMBINANT HUMAN ERYTHROPOETIN (RH-EPO) VERSUS BLOOD TRANSFUSION
Abstract
Authors
DF Ossa E Mclntosh A Briggs W Cowell T Littlewood M Sculpher